The Relationship of Cancer Symptom Clusters to Depressive Affect in the Initial Phase of Palliative Radiation Fulltext Access 26 Pages 2005
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention Fulltext Access 26 Pages 2005
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma Fulltext Access 26 Pages 2005
Drug-drug interactions in oncology: Why are they important and can they be minimized? Fulltext Access 26 Pages 2005
Insights into oxazaphosphorine resistance and possible approaches to its circumvention Fulltext Access 27 Pages 2005
The causes and treatment of bone loss associated with carcinoma of the breast Fulltext Access 28 Pages 2005
Interpreting epithelial cancer biology in the context of stem cells: Tumor properties and therapeutic implications Fulltext Access 28 Pages 2005
Surgical Management of Pelvic Malignancy: Role of Extended Abdominoperineal Resection/Exenteration/Abdominal Sacral Resection Fulltext Access 28 Pages 2005
Vth International Conference of Cancer-Induced Bone Disease (CIBD) - Posters Fulltext Access 28 Pages 2005
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers Fulltext Access 29 Pages 2005
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies Fulltext Access 35 Pages 2005
Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab Fulltext Access 36 Pages 2005
Abstracts of the 26th Annual Meeting of the American Brachytherapy Society Fulltext Access 42 Pages 2005
Abstracts Presented for the Thirty-Sixth Society of Gynecologic Oncologist Fulltext Access 112 Pages 2005